New publications: All the parts which comprise this series (which will be published in the BDJ) have been included (together with a number of unpublished parts) in the books A Clinical Guide to ...

Plant tissues contain cells that are polyhedral in shape. The sharp edges marking the boundaries between adjacent cell faces present an interesting challenge to relatively rigid microtubules (MTs), ...

Clasp founder and CEO Tess Michaels joins Wealth! to discuss her mission of connecting students with employers who will invest in their education and careers. "I actually founded Clasp from a ...

Cancer immunotherapy comes in several forms, and one area of growing research interest is a type of drug called a T cell engager. These drugs bind to a cancer cell and a T cell simultaneously, ...

CAMBRIDGE, Mass. & ROCKVILLE, Md.--(BUSINESS WIRE)--Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation T cell engagers (TCEs), ...

Clasp Therapeutics has burst onto the T-cell engager (TCE) scene with $150 million in funding for a platform that aims to improve the safety of the class, which is currently gaining traction in cancer ...

For such a small task, putting on a necklace or bracelet by yourself takes an immense level of coordination. You have to be able to grasp the tiny clasp, reach behind you and find the ring to fasten ...